MedTrace Logo

DIMS-myopia Progression ADN Axial Length Growth

NCT05300321 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2022-04-25

No results posted yet for this study

Summary

To confirm the efficacy of DIMS lenses in controlling myopia progression, we planned a prospective randomized controlled clinical study.

Conditions

  • Myopia, Progressive

Interventions

DEVICE

frame lens

The subjects were randomized to allocate in Single Vision (SV) lens or Defocus Incorporated Multiple Segments (DIMS) Lens group.

Sponsors & Collaborators

  • Tianjin Eye Hospital

    lead OTHER

Principal Investigators

  • Xiaoqin Chen, MD · Tianjin Eye Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2020-11-30
Completion
2021-04-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05300321 on ClinicalTrials.gov